Tribenoside
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | C05AX05 (WHO) C05CX01 (WHO) |
| Identifiers | |
| |
| Synonyms | (3R,4R,5R)-4-(benzyloxy)-5-[1,2-bis(benzyloxy)ethyl]-2-ethoxyoxolan-3-ol |
| CAS Number |
10310-32-4 |
| PubChem (CID) | 25145 |
| UNII |
Z7N0Y673NU |
| ChEMBL |
CHEMBL1446743 |
| ECHA InfoCard | 100.030.612 |
| Chemical and physical data | |
| Formula | C29H34O6 |
| Molar mass | 478.57666 g/mol |
| | |
Tribenoside (Glyvenol) is a vasoprotective and a mixture of the α- und β-anomers.
Induction of hypersensitivity has been reported.[1]
References
- ↑ Hashizume H, Takigawa M (2005). "Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells". Acta Derm. Venereol. 85 (1): 47–50. doi:10.1080/00015550410024094. PMID 15848991.
This article is issued from Wikipedia - version of the 9/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
